RxDoctor Payments Data

Hanna Sanoff, MD

Hematology & Oncology · Chapel Hill, NCNPI 1053366294

Payments from drug & device makers

What this record shows

This record is dominated by education: $43 of the $43 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, AstraZeneca. That places this record below the midpoint for hematology & oncology clinicians in NC, where the typical reported total is $1,703.

$43in general payments, 2019–2025

Across 1 payment — averaging $43.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$43
$456,699in research payments, 2019–2025

Across 43 payments — averaging $10,621 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$130K
  • AbbVie$120K
  • Janssen Research & Development, LLC$91K
  • AstraZeneca$64K
  • Exelixis Inc.$47K
  • Merck$5K

What the payments were for

  • Education$43100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$43

How this compares

$43 in reported general payments places this provider in the 5th percentile of 358 hematology & oncology providers in North Carolina.

See all hematology & oncology providers in North Carolina →

Medicare billing

Part B allowed, 2024
$34,417
Medicare patients
111
Services billed
439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$13,585
Imatinib Mesylate20$3,212
Oxycodone Hcl19$278
Mirtazapine13$240
Ondansetron Hcl19$149
Prochlorperazine Maleate13$134

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Chapel Hill

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →